Medical researchers unveiled clinical trials of new anti-AIDS drug that better controls the spread of the deadly virus among previously untreated patients.
UCB announced that the U.S. Food and Drug Administration (FDA) has approved Vimpat® (lacosamide), a new antiepileptic drug (AED). Vimpat® is for use as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older.
New Mexico Software, Inc., a leading services provider of next-generation business and medical products, announced today that the company has obtained 510(k) clearance for its XR-EXpress Picture Archiving and Communication System (PACS) from the U.S. Food and Drug Administration (FDA).
The National Agency for Food and Drug Administration and Control (NAFDAC) has banned 22 firms that it says are involved in the manufacture of fake drugs from ever again selling pharmaceuticals in Nigeria, as part of a countrywide clampdown.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) has submitted a New Drug Application to the US Food and Drug Administration (FDA) for carisbamate, a new investigational compound for the adjunctive treatment of partial onset seizures in patients 16 years of age and older.
Agilent and BioTrove have forged a non-exclusive mass spectrometry partnership designed to enhance the screening of candidate drug compounds in early stage development.
Bharat Biotech International Ltd (BBIL), a producer of vaccines and biotherapeutics announced that the Orissa government has selected the company as the developer for its ‘Biotech-Pharma-IT Park’ project under public-private-partnership (PPP) mode.
Rib-X Pharmaceuticals, Inc., a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive results from a Phase 2 clinical trial with the oral form of its compound, radezolid (RX-1741), for the treatment of uncomplicated skin and skin structure infections (uSSSI).
Patients taking Selzentry, in combination with Combivir® (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to screen patients, experienced a 68 percent rate of virologic suppression to undetectable levels, according to the MERIT ES.
The Savient Pharmaceuticals drug, called pegloticase, helped remove uric acid, which causes the painful, needle-like crystals that clump around fingers, toes and other joints in the condition.
Incyte Corporation announced the presentation of clinical results from a 28-day Phase IIa trial of INCB18424, its orally available janus kinase (JAK) inhibitor, in patients with rheumatoid arthritis (RA).
Drug-maker Glenmark’s net profit for the second quarter ended 30 September grew by 56.23% at Rs117.36 crore over the corresponding period a year ago.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a negative opinion on a Cymbalta® (duloxetine hydrochloride) application for the treatment of fibromyalgia.
Maharashtra, the cradle of the Indian pharmaceutical industry, continues to maintain its domination in this field…….[English]-[French]-[Spanish]
Humanitarian Device Exemption Allows IBV(R) Valve System As Minimally Invasive Treatment Alternative for Patients with Prolonged Post-Operative Air Leaks.
NeurogesX, Inc, a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the US Food and Drug Administration (FDA) for approval to market its investigational product candidate, NGX-4010, for the management of pain due to postherpetic neuralgia (PHN).
GlaxoSmithKline (GSK) has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) for Alli (Orlistat 60mg) as a non-prescription product.
GlaxoSmithKline is buying Biotene, the top dry mouth brand, from privately held Laclede for $170 million to strengthen its therapeutic oral healthcare portfolio.
India and Russia will now take forward the collaborative science programmes to new areas like ocean research, gas hydrides for energy security and nanotechnology and work for transfer of technology for industry. The research in the emerging areas would help India achieve energy security and use technology for the benefit of the public.
ImmunoCellular Therapeutics, Ltd, a biotechnology company, announced the issuance of two separate US patents relating to the company's monoclonal antibody therapeutics. Patents no 7,435,415 and no 7,435,554 are both entitled 'Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)'.